DiaMedica Therapeutics (DMAC) Cash & Current Investments (2018 - 2019)
DiaMedica Therapeutics (DMAC) has 2 years of Cash & Current Investments data on record, last reported at $9.7 million in Q3 2019.
- For Q3 2019, Cash & Current Investments rose 149.95% year-over-year to $9.7 million; the TTM value through Sep 2019 reached $9.7 million, up 149.95%, while the annual FY2018 figure was $16.8 million, N/A changed from the prior year.
- Cash & Current Investments reached $9.7 million in Q3 2019 per DMAC's latest filing, down from $11.0 million in the prior quarter.
- Across five years, Cash & Current Investments topped out at $16.8 million in Q4 2018 and bottomed at $3.9 million in Q3 2018.